Progressive Care (RXMD) Stock Price, News & Analysis

Company Overview

Progressive Care Inc. (OTCMKTS: RXMD) is a U.S.-based provider of diagnostic testing and preventive health services, specializing in mobile and facility-based solutions. The company offers a range of point-of-care testing options and full laboratory services, catering to both corporate and clinical clients. Progressive Care’s service offerings are designed to support occupational health, school testing programs, long-term care facilities and community health initiatives.

The company’s core activities include drug and alcohol screening, physical examinations, immunizations and wellness screenings. Progressive Care operates a fleet of mobile testing units that can be dispatched directly to client sites, as well as fixed-location testing centers. Its testing portfolio encompasses infectious disease assays (including COVID-19, influenza and strep), cardiac markers, metabolic panels and other routine laboratory tests. Through its mobile and on-site approach, the company aims to reduce logistical barriers for employers, schools and care facilities.

Progressive Care also develops and distributes automated point-of-care testing platforms and related reagents, enabling rapid results in off-site environments. Its proprietary systems are used to streamline sample collection and analysis, accelerating turnaround times for critical diagnostic information. The company’s services are supported by a network of certified healthcare professionals and medical technologists, ensuring compliance with regulatory and quality standards.

Serving clients across multiple U.S. states, Progressive Care focuses on scalable solutions for organizations looking to implement comprehensive health screening programs. While headquartered in Pennsylvania, the company’s mobile model allows it to address testing needs in urban, suburban and rural communities. Progressive Care’s leadership team brings experience in healthcare operations, laboratory science and corporate wellness strategy, driving the company’s efforts to expand its diagnostic footprint and service offerings.

Key Stats

• Today's Range: $2.11 to $2.11
• 50-Day Range: $2.11 to $2.11
• 52-Week Range: $0.40 to $4.50
• Volume: N/A
• Average Volume: 2,561 shs
• Market Capitalization: $13.17 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 8/02/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Discretionary
• Industry: Drug stores & proprietary stores
• Sub-Industry: Retail
• Current Symbol: OTCMKTS:RXMD
• CIK: 1402945
• Web: progressivecareus.com
• Phone: (786) 657-2060
• Fax: 786-657-2904
• Employees: 31
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($3.47)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$19.42 million
• Net Margins: -44.27%
• Pretax Margin: -44.27%
• Return on Equity: -59.80%
• Return on Assets: -38.20%

Debt

• Debt-to-Equity Ratio: 0.06
• Current Ratio: 2.01
• Quick Ratio: 1.79

Sales & Book Value

• Annual Sales: $49.73 million
• Price / Sales: 0.26
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.26 per share
• Price / Book: 0.50

Miscellaneous

• Outstanding Shares: 6,241,000
• Free Float: 6,031,000
• Market Cap: $13.17 million
• Optionable: Not Optionable
• Beta: -0.21